Novo Nordisk Brazil

Last updated: 13.02.2014

Address: Av. Francisco Matarazzo, 1500 – 13º andar – Ed. New York – Bairro Água Branca – São Paulo – SP,Brazil

Tel: (11) 3868.9100


Company description

Novo Nordisk is a world leader in diabetes care. In addition, the company has a leading position in areas such as haemostasis management, growth hormone therapy and replacement therapy hormonal. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, physicians and society. With headquarters in Denmark, Novo Nordisk employs approximately 30,900 people in 79 countries and sells products in 179 countries.

Present in Brazil since 1990, Novo Nordisk has consolidated its presence in the country in 2002 when it bought the lab Biobrás – the only domestic producer of insulin. Reaffirming the company’s interest and commitment to the country in April 2007, Novo Nordisk launched the largest insulin plant in Latin America, in Montes Claros – MG, with investments of over U.S. $ 200 million.

During these two decades, the Brazilian affiliate has consolidated its presence in Diabetes, Hemophilia Growth Hormone and contributing to change the lives of patients around the country.

Products and services

Diabetes, Haemophilia, Growth Hormone



We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here